Heather Gelhorn
Overview
Explore the profile of Heather Gelhorn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gelhorn H, Ross M, Kansal A, Fung E, Seiden M, Krucien N, et al.
Patient
. 2022 Jul;
16(1):43-56.
PMID: 35844011
Background: Emerging blood-based multi-cancer early detection (MCED) tests can detect a variety of cancer types across stages with a range of sensitivity, specificity, and ability to predict the origin of...
2.
Gelhorn H, Garris C, Arthurs E, Spinelli F, Cutts K, Chua G, et al.
J Pers Med
. 2022 Mar;
12(3).
PMID: 35330334
A long-acting injectable (LAI) antiretroviral therapy (ART) regimen is now available as a treatment option for virologically suppressed adults with HIV-1. This study assessed preference for a LAI regimen using...
3.
Schmidt M, Rohayem J, Zitzmann M, Gelhorn H, Schneider G
Andrologia
. 2022 Jan;
54(4):e14370.
PMID: 35060154
In German, the 'Aging Males' Symptom Scale (AMS)' is available for the assessment of symptoms of hypogonadism in men of advanced age. An English questionnaire named 'Hypogonadism Impact of Symptoms'...
4.
Lenderking W, Anatchkova M, Pokrzywinski R, Skalicky A, Martin M, Gelhorn H
J Patient Rep Outcomes
. 2021 Jul;
5(1):61.
PMID: 34283357
Background: There has been a growing emphasis on health-related quality of life (HRQoL) as an important outcome in rare disease drug development, although its assessment may be useful outside the...
5.
Gelhorn H, Balantac Z, Shinde S, Thieu V, Boye K
Diabetes Ther
. 2021 May;
12(7):1821-1837.
PMID: 34043162
Introduction: Type 2 diabetes (T2D) is extremely burdensome to people with T2D and associated with impaired health-related quality of life. This study explores the impact of T2D and potentially relevant...
6.
Tervonen T, Jimenez-Moreno A, Krucien N, Gelhorn H, Marsh K, Heidenreich S
Patient
. 2020 Dec;
14(3):373-377.
PMID: 33313991
No abstract available.
7.
Boye K, Ross M, Mody R, Konig M, Gelhorn H
Diabetes Obes Metab
. 2020 Nov;
23(2):508-519.
PMID: 33140575
Aims: To understand patient preferences for once-daily oral versus once-weekly injectable type 2 diabetes mellitus (T2DM) medication administration profiles, and reasons for their preferences. Materials And Methods: The REVISE study,...
8.
Jones P, Gelhorn H, Wilson H, Benson V, Karlsson N, Menjoge S, et al.
Chronic Obstr Pulm Dis
. 2017 Aug;
4(2):150-158.
PMID: 28848924
: Randomized controlled trials (RCTs) often recruit patients from low and high socioeconomic status (SES) countries, but little is known about the effect of SES on clinical outcomes, particularly patient-centered...
9.
Mullerova H, Gelhorn H, Wilson H, Benson V, Karlsson N, Menjoge S, et al.
Chronic Obstr Pulm Dis
. 2017 Aug;
4(2):141-149.
PMID: 28848923
We aimed to estimate the usefulness of a disease specific health status measure, the St George's Respiratory Questionnaire (SGRQ), to predict outcomes in patients with chronic obstructive pulmonary disease (COPD)....
10.
Jones P, Gelhorn H, Karlsson N, Menjoge S, Mullerova H, Rennard S, et al.
Chronic Obstr Pulm Dis
. 2017 Aug;
4(2):132-140.
PMID: 28848922
In trials oflong-acting bronchodilators, health status is an important trial outcome, however the influence of baseline severity on response measured by St George's Respiratory Questionnaire (SGRQ) is not known. We...